Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1581 entries
Sorted by: Best Match Show Resources per page
Capability and limitations of recent diagnostic criteria for autoimmune pancreatitis.

International journal of rheumatology

Tabata T, Kamisawa T, Kuruma S, Chiba K, Iwasaki S, Kuwata G, Fujiwara T, Egashira H, Koizumi S, Endo Y, Koizumi K, Fujiwara J, Arakawa T, Momma K.
PMID: 24288540
Int J Rheumatol. 2013;2013:465428. doi: 10.1155/2013/465428. Epub 2013 Oct 30.

Because a diagnostic serological marker is unavailable, autoimmune pancreatitis (AIP) is diagnosed based on unique features. The diagnostic capabilities and potential limitations of four sets of diagnostic criteria for AIP (Japanese diagnostic criteria 2006 and 2011, Asian diagnostic criteria,...

Cite
Tabata T, Kamisawa T, Kuruma S, et al. Capability and limitations of recent diagnostic criteria for autoimmune pancreatitis. Int J Rheumatol. 2013;2013:465428doi: 10.1155/2013/465428.
Tabata, T., Kamisawa, T., Kuruma, S., Chiba, K., Iwasaki, S., Kuwata, G., Fujiwara, T., Egashira, H., Koizumi, S., Endo, Y., Koizumi, K., Fujiwara, J., Arakawa, T., & Momma, K. (2013). Capability and limitations of recent diagnostic criteria for autoimmune pancreatitis. International journal of rheumatology, 2013465428. https://doi.org/10.1155/2013/465428
Tabata, Taku, et al. "Capability and limitations of recent diagnostic criteria for autoimmune pancreatitis." International journal of rheumatology vol. 2013 (2013): 465428. doi: https://doi.org/10.1155/2013/465428
Tabata T, Kamisawa T, Kuruma S, Chiba K, Iwasaki S, Kuwata G, Fujiwara T, Egashira H, Koizumi S, Endo Y, Koizumi K, Fujiwara J, Arakawa T, Momma K. Capability and limitations of recent diagnostic criteria for autoimmune pancreatitis. Int J Rheumatol. 2013;2013:465428. doi: 10.1155/2013/465428. Epub 2013 Oct 30. PMID: 24288540; PMCID: PMC3833014.
Copy Download .nbib Format: NLM
Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

Open journal of rheumatology and autoimmune diseases

Hoganson DD, Chen J, Ehman RL, Talwalkar JA, Michet CJ, Yin M, Crowson CS, Matteson EL.
PMID: 26361561
Open J Rheumatol Autoimmune Dis. 2012 May;2(2):6-13. doi: 10.4236/ojra.2012.22003.

INTRODUCTION: Hepatic magnetic resonance elastography (MRE) allows for noninvasive assessment of liver fibrosis. The purpose of this study was to evaluate the usefulness of MRE in detecting and quantifying liver fibrosis in patients with rheumatoid arthritis (RA) who have...

Cite
Hoganson DD, Chen J, Ehman RL, et al. Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment. Open J Rheumatol Autoimmune Dis. 2012;2(2):6-13doi: 10.4236/ojra.2012.22003.
Hoganson, D. D., Chen, J., Ehman, R. L., Talwalkar, J. A., Michet, C. J., Yin, M., Crowson, C. S., & Matteson, E. L. (2012). Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment. Open journal of rheumatology and autoimmune diseases, 2(2), 6-13. https://doi.org/10.4236/ojra.2012.22003
Hoganson, Deana D, et al. "Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment." Open journal of rheumatology and autoimmune diseases vol. 2,2 (2012): 6-13. doi: https://doi.org/10.4236/ojra.2012.22003
Hoganson DD, Chen J, Ehman RL, Talwalkar JA, Michet CJ, Yin M, Crowson CS, Matteson EL. Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment. Open J Rheumatol Autoimmune Dis. 2012 May;2(2):6-13. doi: 10.4236/ojra.2012.22003. PMID: 26361561; PMCID: PMC4562680.
Copy Download .nbib Format: NLM
Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.

The Journal of rheumatology

[No authors listed]
PMID: 28864670
J Rheumatol. 2017 Sep;44(9):1417. doi: 10.3899/jrheum.160871.C1.

No abstract available.

Cite
Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. J Rheumatol. 2017;44(9):1417doi: 10.3899/jrheum.160871.C1.
(2017). Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. The Journal of rheumatology, 44(9), 1417. https://doi.org/10.3899/jrheum.160871.C1
"Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients." The Journal of rheumatology vol. 44,9 (2017): 1417. doi: https://doi.org/10.3899/jrheum.160871.C1
Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. J Rheumatol. 2017 Sep;44(9):1417. doi: 10.3899/jrheum.160871.C1. PMID: 28864670.
Copy Download .nbib Format: NLM
Defining Chronic Pain.

The Journal of rheumatology

Ruan X, Kaye AD.
PMID: 27037243
J Rheumatol. 2016 Apr;43(4):826. doi: 10.3899/jrheum.150807.

No abstract available.

Cite
Ruan X, Kaye AD. Defining Chronic Pain. J Rheumatol. 2016;43(4):826doi: 10.3899/jrheum.150807.
Ruan, X., & Kaye, A. D. (2016). Defining Chronic Pain. The Journal of rheumatology, 43(4), 826. https://doi.org/10.3899/jrheum.150807
Ruan, Xiulu, and Kaye, Alan David. "Defining Chronic Pain." The Journal of rheumatology vol. 43,4 (2016): 826. doi: https://doi.org/10.3899/jrheum.150807
Ruan X, Kaye AD. Defining Chronic Pain. J Rheumatol. 2016 Apr;43(4):826. doi: 10.3899/jrheum.150807. PMID: 27037243.
Copy Download .nbib Format: NLM
Long-term remission of corticosteroid- and cyclophosphamide-resistant Henoch-Schönlein purpura with rituximab.

Scandinavian journal of rheumatology

Bellan M, Pirisi M, Sainaghi PP.
PMID: 26312648
Scand J Rheumatol. 2016 Jan;45(1):83-84. doi: 10.3109/03009742.2015.1058417. Epub 2015 Aug 31.

No abstract available.

Cite
Bellan M, Pirisi M, Sainaghi PP. Long-term remission of corticosteroid- and cyclophosphamide-resistant Henoch-Schönlein purpura with rituximab. Scand J Rheumatol. 2015;45(1):83-84doi: 10.3109/03009742.2015.1058417.
Bellan, M., Pirisi, M., & Sainaghi, P. P. (2016). Long-term remission of corticosteroid- and cyclophosphamide-resistant Henoch-Schönlein purpura with rituximab. Scandinavian journal of rheumatology, 45(1), 83-84. https://doi.org/10.3109/03009742.2015.1058417
Bellan, M, et al. "Long-term remission of corticosteroid- and cyclophosphamide-resistant Henoch-Schönlein purpura with rituximab." Scandinavian journal of rheumatology vol. 45,1 (2016): 83-84. doi: https://doi.org/10.3109/03009742.2015.1058417
Bellan M, Pirisi M, Sainaghi PP. Long-term remission of corticosteroid- and cyclophosphamide-resistant Henoch-Schönlein purpura with rituximab. Scand J Rheumatol. 2016 Jan;45(1):83-84. doi: 10.3109/03009742.2015.1058417. Epub 2015 Aug 31. PMID: 26312648.
Copy Download .nbib Format: NLM
Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East.

International journal of rheumatology

Hammoudeh M, Al Awadhi A, Hasan EH, Akhlaghi M, Ahmadzadeh A, Sadeghi Abdollahi B.
PMID: 26089907
Int J Rheumatol. 2015;2015:975028. doi: 10.1155/2015/975028. Epub 2015 May 19.

This open-label study investigated the safety and efficacy of tocilizumab in Middle Eastern patients with rheumatoid arthritis (RA). Patients whose Disease Activity Score based on 28 joints (DAS28) was >3.2 received tocilizumab 8 mg/kg intravenously every 4 weeks for...

Cite
Hammoudeh M, Al Awadhi A, Hasan EH, et al. Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East. Int J Rheumatol. 2015;2015:975028doi: 10.1155/2015/975028.
Hammoudeh, M., Al Awadhi, A., Hasan, E. H., Akhlaghi, M., Ahmadzadeh, A., & Sadeghi Abdollahi, B. (2015). Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East. International journal of rheumatology, 2015975028. https://doi.org/10.1155/2015/975028
Hammoudeh, Mohammed, et al. "Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East." International journal of rheumatology vol. 2015 (2015): 975028. doi: https://doi.org/10.1155/2015/975028
Hammoudeh M, Al Awadhi A, Hasan EH, Akhlaghi M, Ahmadzadeh A, Sadeghi Abdollahi B. Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East. Int J Rheumatol. 2015;2015:975028. doi: 10.1155/2015/975028. Epub 2015 May 19. PMID: 26089907; PMCID: PMC4452319.
Copy Download .nbib Format: NLM
The OMERACT First-time Participant ("Newbie") Program: Initial Assessment and Lessons Learned.

The Journal of rheumatology

Sloan VS, Grosskleg S, Pohl C, Wells GA, Singh JA.
PMID: 26034159
J Rheumatol. 2015 Oct;42(10):1976-1981. doi: 10.3899/jrheum.141200. Epub 2015 Jun 01.

OBJECTIVE: To describe the experience of a first-time participant ("newbie") training program at the Outcome Measures in Rheumatology 12 meeting in 2014.METHODS: We conducted newbie sessions at OMERACT 12, including a 2-hour introductory session on Day 1, followed by...

Cite
Sloan VS, Grosskleg S, Pohl C, et al. The OMERACT First-time Participant ("Newbie") Program: Initial Assessment and Lessons Learned. J Rheumatol. 2015;42(10):1976-1981doi: 10.3899/jrheum.141200.
Sloan, V. S., Grosskleg, S., Pohl, C., Wells, G. A., & Singh, J. A. (2015). The OMERACT First-time Participant ("Newbie") Program: Initial Assessment and Lessons Learned. The Journal of rheumatology, 42(10), 1976-1981. https://doi.org/10.3899/jrheum.141200
Sloan, Victor S, et al. "The OMERACT First-time Participant ("Newbie") Program: Initial Assessment and Lessons Learned." The Journal of rheumatology vol. 42,10 (2015): 1976-1981. doi: https://doi.org/10.3899/jrheum.141200
Sloan VS, Grosskleg S, Pohl C, Wells GA, Singh JA. The OMERACT First-time Participant ("Newbie") Program: Initial Assessment and Lessons Learned. J Rheumatol. 2015 Oct;42(10):1976-1981. doi: 10.3899/jrheum.141200. Epub 2015 Jun 01. PMID: 26034159.
Copy Download .nbib Format: NLM
Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT.

The Journal of rheumatology

Phillips K, Taylor A, Mease PJ, Simon LS, Conaghan PG, Choy EH, Singh JA, Strand V, Gossec L, Kaiser U, de Wit M, Ostelo R, Maxwell L, Tugwell PS.
PMID: 26233508
J Rheumatol. 2015 Oct;42(10):1943-1946. doi: 10.3899/jrheum.141386. Epub 2015 Aug 01.

OBJECTIVE: A variety of authorities in pain measurement and outcome methodology met prior to the Outcome Measures in Rheumatology (OMERACT) 12 meeting in May 2014 to develop partnerships for consensus on pain outcomes.METHODS: Following overview presentations, discussion centered on...

Cite
Phillips K, Taylor A, Mease PJ, et al. Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT. J Rheumatol. 2015;42(10):1943-1946doi: 10.3899/jrheum.141386.
Phillips, K., Taylor, A., Mease, P. J., Simon, L. S., Conaghan, P. G., Choy, E. H., Singh, J. A., Strand, V., Gossec, L., Kaiser, U., de Wit, M., Ostelo, R., Maxwell, L., & Tugwell, P. S. (2015). Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT. The Journal of rheumatology, 42(10), 1943-1946. https://doi.org/10.3899/jrheum.141386
Phillips, Kristine, et al. "Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT." The Journal of rheumatology vol. 42,10 (2015): 1943-1946. doi: https://doi.org/10.3899/jrheum.141386
Phillips K, Taylor A, Mease PJ, Simon LS, Conaghan PG, Choy EH, Singh JA, Strand V, Gossec L, Kaiser U, de Wit M, Ostelo R, Maxwell L, Tugwell PS. Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT. J Rheumatol. 2015 Oct;42(10):1943-1946. doi: 10.3899/jrheum.141386. Epub 2015 Aug 01. PMID: 26233508.
Copy Download .nbib Format: NLM
IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.

European journal of rheumatology

Raymond W, Ostli-Eilertsen G, Griffiths S, Nossent J.
PMID: 28293450
Eur J Rheumatol. 2017 Mar;4(1):29-35. doi: 10.5152/eurjrheum.2017.16059. Epub 2017 Mar 01.

OBJECTIVE: The interleukin 17 (IL-17) cytokine family is involved in a number of chronic inflammatory diseases. In spite of contradictory findings and a lack of causality in clinical studies, IL-17 inhibition for systemic lupus erythematosus (SLE) has regained attention...

Cite
Raymond W, Ostli-Eilertsen G, Griffiths S, et al. IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role. Eur J Rheumatol. 2017;4(1):29-35doi: 10.5152/eurjrheum.2017.16059.
Raymond, W., Ostli-Eilertsen, G., Griffiths, S., & Nossent, J. (2017). IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role. European journal of rheumatology, 4(1), 29-35. https://doi.org/10.5152/eurjrheum.2017.16059
Raymond, Warren, et al. "IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role." European journal of rheumatology vol. 4,1 (2017): 29-35. doi: https://doi.org/10.5152/eurjrheum.2017.16059
Raymond W, Ostli-Eilertsen G, Griffiths S, Nossent J. IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role. Eur J Rheumatol. 2017 Mar;4(1):29-35. doi: 10.5152/eurjrheum.2017.16059. Epub 2017 Mar 01. PMID: 28293450; PMCID: PMC5335884.
Copy Download .nbib Format: NLM
Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?.

European journal of rheumatology

Sacks S, Steuer A.
PMID: 28293454
Eur J Rheumatol. 2017 Mar;4(1):57-58. doi: 10.5152/eurjrheum.2017.160058. Epub 2017 Mar 01.

We report regarding a male patient who presented with a systemic vasculitis that was consistent with a diagnosis of polyarteritis nodosa. At presentation, he had no features of inflammatory arthritis but had a high rheumatoid factor titer and low...

Cite
Sacks S, Steuer A. Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?. Eur J Rheumatol. 2017;4(1):57-58doi: 10.5152/eurjrheum.2017.160058.
Sacks, S., & Steuer, A. (2017). Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?. European journal of rheumatology, 4(1), 57-58. https://doi.org/10.5152/eurjrheum.2017.160058
Sacks, Sarah, and Steuer, Alan. "Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?." European journal of rheumatology vol. 4,1 (2017): 57-58. doi: https://doi.org/10.5152/eurjrheum.2017.160058
Sacks S, Steuer A. Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?. Eur J Rheumatol. 2017 Mar;4(1):57-58. doi: 10.5152/eurjrheum.2017.160058. Epub 2017 Mar 01. PMID: 28293454; PMCID: PMC5335888.
Copy Download .nbib Format: NLM
Viscosupplementation of the knee: Three cases of acute Pseudoseptic Arthritis with painful and irritating complications and a literature review.

European journal of rheumatology

Aydın M, Arıkan M, Toğral G, Varış O, Aydın G.
PMID: 28293455
Eur J Rheumatol. 2017 Mar;4(1):59-62. doi: 10.5152/eurjrheum.2016.15075. Epub 2017 Mar 01.

Acute pseudoseptic arthritis is a very rare complication that is associated with intra-articular hyaluronic acid injections, which normally involve minimal risk. The most common adverse events that are caused by hyaluronic acid injections are inflammatory reactions or flares at...

Cite
Aydın M, Arıkan M, Toğral G, et al. Viscosupplementation of the knee: Three cases of acute Pseudoseptic Arthritis with painful and irritating complications and a literature review. Eur J Rheumatol. 2017;4(1):59-62doi: 10.5152/eurjrheum.2016.15075.
Aydın, M., Arıkan, M., Toğral, G., Varış, O., & Aydın, G. (2017). Viscosupplementation of the knee: Three cases of acute Pseudoseptic Arthritis with painful and irritating complications and a literature review. European journal of rheumatology, 4(1), 59-62. https://doi.org/10.5152/eurjrheum.2016.15075
Aydın, Murat, et al. "Viscosupplementation of the knee: Three cases of acute Pseudoseptic Arthritis with painful and irritating complications and a literature review." European journal of rheumatology vol. 4,1 (2017): 59-62. doi: https://doi.org/10.5152/eurjrheum.2016.15075
Aydın M, Arıkan M, Toğral G, Varış O, Aydın G. Viscosupplementation of the knee: Three cases of acute Pseudoseptic Arthritis with painful and irritating complications and a literature review. Eur J Rheumatol. 2017 Mar;4(1):59-62. doi: 10.5152/eurjrheum.2016.15075. Epub 2017 Mar 01. PMID: 28293455; PMCID: PMC5335889.
Copy Download .nbib Format: NLM
Acute digital ischemia: A rare presentation of antisynthetase syndrome.

European journal of rheumatology

Chan JE, Palakodeti S, Koster MJ.
PMID: 28293456
Eur J Rheumatol. 2017 Mar;4(1):63-65. doi: 10.5152/eurjrheum.2017.16077. Epub 2017 Mar 01.

Antisynthetase syndrome (ASS) is recognized as a subgroup of idiopathic inflammatory myopathies (IIMs). It is associated with autoantibodies directed against aminoacyl-transfer ribonucleic acid (tRNA) synthetase enzymes. We report the first case of anti-PL-7/anti-SSA 52kD ASS presenting as acute digital...

Cite
Chan JE, Palakodeti S, Koster MJ. Acute digital ischemia: A rare presentation of antisynthetase syndrome. Eur J Rheumatol. 2017;4(1):63-65doi: 10.5152/eurjrheum.2017.16077.
Chan, J. E., Palakodeti, S., & Koster, M. J. (2017). Acute digital ischemia: A rare presentation of antisynthetase syndrome. European journal of rheumatology, 4(1), 63-65. https://doi.org/10.5152/eurjrheum.2017.16077
Chan, Jin Ei, et al. "Acute digital ischemia: A rare presentation of antisynthetase syndrome." European journal of rheumatology vol. 4,1 (2017): 63-65. doi: https://doi.org/10.5152/eurjrheum.2017.16077
Chan JE, Palakodeti S, Koster MJ. Acute digital ischemia: A rare presentation of antisynthetase syndrome. Eur J Rheumatol. 2017 Mar;4(1):63-65. doi: 10.5152/eurjrheum.2017.16077. Epub 2017 Mar 01. PMID: 28293456; PMCID: PMC5335890.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1581 entries